Phase I dose ‐escalation trial of Sym004, an anti‐EGFR antibody mixture, in Japanese patients with advanced solid tumors

Cancer Science,Volume 0, Issue ja, -Not available-.

Source: Cancer Science - August 12, 2018 Category: Cancer & Oncology Authors: Takashi Kojima , Kentaro Yamazaki , Ken Kato , Kei Muro , Hiroki Hara , Keisho Chin , Thomas Goddemeier , Stefan Kuffel , Morihiro Watanabe , Toshihiko Doi Source Type: research